Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Erill

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
International Journal of Clinical Pharmacology and Biopharmacy|April 1, 1979
Plasma protein binding of salicylate and quinidine in patients with multiple myelomaM Perez-Mateo, S Erill
European Journal of Clinical Pharmacology|November 9, 1978
Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failureP du Souich, S Erill
Clinical Pharmacology and Therapeutics|November 1, 1977
Metabolism of procainamide and p-aminobenzoic acid in patients with chronic liver diseaseP du Souich, S Erill
Archivos De Farmacologia Y Toxicologia|March 1, 1975
[Rifampicin. Interactions with other drugs]J A Salvá, S Erill
Archivos De Farmacologia Y Toxicologia|March 1, 1975
[Rifampicin: interactions with other drugs]J A Salvá, S Erill
International Journal of Clinical Pharmacology Research|January 1, 1986
Serum protein binding of model acidic drugs in smokers and non-smokersF Ruiz-Cabello, S Erill
Medicina Clinica|March 14, 1987
[Pharmacokinetics and drug therapy]S Erill, P du Souich
European Journal of Clinical Pharmacology|March 11, 1977
Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiencyM Pérez-Mateo, S Erill
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1982
A study of package inserts of potentially toxic drugsJ M Rodríguez-Sasiaín, S Erill
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1981
Plasma protein binding of etomidate in different age groups and in patients with chronic respiratory insufficiencyR Carlos, R Calvo, S Erill
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
International Journal of Clinical Pharmacology and Biopharmacy|April 1, 1979
Plasma protein binding of salicylate and quinidine in patients with multiple myelomaM Perez-Mateo, S Erill
European Journal of Clinical Pharmacology|November 9, 1978
Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failureP du Souich, S Erill
Clinical Pharmacology and Therapeutics|November 1, 1977
Metabolism of procainamide and p-aminobenzoic acid in patients with chronic liver diseaseP du Souich, S Erill
Archivos De Farmacologia Y Toxicologia|March 1, 1975
[Rifampicin. Interactions with other drugs]J A Salvá, S Erill
Archivos De Farmacologia Y Toxicologia|March 1, 1975
[Rifampicin: interactions with other drugs]J A Salvá, S Erill
International Journal of Clinical Pharmacology Research|January 1, 1986
Serum protein binding of model acidic drugs in smokers and non-smokersF Ruiz-Cabello, S Erill
Medicina Clinica|March 14, 1987
[Pharmacokinetics and drug therapy]S Erill, P du Souich
European Journal of Clinical Pharmacology|March 11, 1977
Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiencyM Pérez-Mateo, S Erill
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1982
A study of package inserts of potentially toxic drugsJ M Rodríguez-Sasiaín, S Erill
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1981
Plasma protein binding of etomidate in different age groups and in patients with chronic respiratory insufficiencyR Carlos, R Calvo, S Erill
Pageof 6